| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -24,732 | 9,861 | 13,889 | -6,703 |
| Depreciation and amortization | 44,967 | 40,852 | 39,799 | 71,476 |
| Noncash operating lease expense | 16,298 | 15,262 | 15,249 | 29,356 |
| Equity in earnings of joint ventures, net of dividends | 1,069 | 1,213 | 3,323 | 1,267 |
| Amortization of deferred financing costs and loan discount | 779 | 772 | 771 | 1,471 |
| Loss on sale and disposal of equipment | -2,591 | -6,490 | -1,042 | -2,126 |
| Loss on extinguishment of debt | NaN | 0 | 0 | 0 |
| Gain on contribution of imaging centers into joint venture | NaN | 0 | NaN | NaN |
| Lease abandonment charges | 0 | -233 | -2,819 | -5,511 |
| Amortization of cash flow hedge | 0 | 0 | -439 | 2,712 |
| Non-cash change in fair value of interest rate swap | 0 | -679 | -2,371 | -4,062 |
| Stock-based compensation | 31,375 | 8,325 | 9,041 | 37,235 |
| Loss on impairment | NaN | 0 | 0 | NaN |
| Change in valuation of contingent consideration | -2,764 | 111 | 0 | 0 |
| Accounts receivable | -9,375 | -10,916 | 6,317 | 14,159 |
| Other current assets | 6,172 | -186 | 20,288 | -22,381 |
| Other assets | 660 | 2,946 | 220 | 2,544 |
| Deferred taxes | 9,099 | -10,826 | -3,513 | 3,511 |
| Operating leases | -13,299 | -14,056 | -14,034 | -34,726 |
| Deferred revenue | 234 | -1,121 | 3,789 | 145 |
| Accounts payable, accrued expenses and other | 31,148 | -1,013 | 5,165 | 48,264 |
| Net cash provided by operating activities | 78,972 | 84,164 | 52,827 | 161,829 |
| Purchase of imaging facilities and other acquisitions, net of cash acquired | 304,151 | 66,958 | 34,479 | 31,985 |
| Proceeds from issuance of debt, net of issuance costs | NaN | 99,001 | NaN | NaN |
| Purchase of property and equipment and other | 69,932 | 51,030 | 60,445 | 101,776 |
| Sale of noncontrolling interests | NaN | 2,389 | NaN | NaN |
| Proceeds from sale of equipment | 277 | 1,213 | 35 | 40 |
| Payments of contingent consideration and holdbacks | NaN | 2,249 | 0 | 0 |
| Equity contributions in existing and purchase of interest in joint ventures | 0 | 0 | -16,333 | 20,480 |
| Proceeds from sale of economic interests in majority owned subsidiary, net of taxes | NaN | NaN | 0 | 0 |
| Proceeds from issuance of new debt, net of issuing costs | NaN | NaN | 0 | 99,001 |
| Collection of notes receivable | 2,833 | 2,835 | 2,832 | NaN |
| Purchase of noncontrolling interests by third party | NaN | NaN | 0 | 2,389 |
| Net cash used in investing activities | -370,973 | -113,940 | -75,724 | -154,201 |
| Principal payments on notes and leases payable | 9,953 | 1,796 | 1,768 | 3,461 |
| Proceeds from issuance of common stock | NaN | 0 | 0 | 0 |
| Payments on term loan debt | 5,252 | 5,252 | 5,252 | 10,252 |
| Distributions paid to noncontrolling interests | 2,402 | 1,289 | 0 | 3,313 |
| Proceeds from issuance of common stock upon exercise of options | 103 | 3,191 | 1,704 | 554 |
| Net cash used in financing activities | -17,504 | -7,395 | -5,316 | 84,918 |
| Effect of exchange rate changes on cash | -2,371 | -330 | -223 | 586 |
| Net decrease in cash and cash equivalents | -311,876 | -37,501 | -28,436 | 93,132 |
| Cash and cash equivalents, beginning of period | 767,215 | 804,716 | 740,020 | NaN |
| Cash and cash equivalents, end of period | 455,339 | 767,215 | 804,716 | NaN |
RadNet, Inc. (RDNT)
RadNet, Inc. (RDNT)